Xiaoyue Cai
Overview
Explore the profile of Xiaoyue Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao Y, Li Y, Su M, Cai X
Cent Eur J Immunol
. 2025 Feb;
49(4):383-392.
PMID: 39944255
Introduction: Acute kidney injury (AKI) is a common complication of sepsis, characterized by sharply declining renal function. As a global concern, understanding its pathogenesis and improving diagnosis and therapy face...
2.
Cai X, Wu G, Lin Y, Yang L
Front Pharmacol
. 2024 Dec;
15:1476587.
PMID: 39712488
Background And Objective: Uremic pruritus is a persistent condition that is difficult to cure in patients with end-stage renal disease who are having regular dialysis. It is highly prevalent, and...
3.
Qiu X, Geng Y, Cai X, Ou Y, Li M, Zhang Y, et al.
Int J Biol Macromol
. 2024 Oct;
282(Pt 1):136617.
PMID: 39426768
The root of Stemona tuberosa Lour has been used to treat tuberculosis, scabies, and eczema. Polysaccharides are among its main bioactive ingredients. A low-molecular-weight (1819 Da) polysaccharide (SPS2-A) was obtained...
4.
Yang Y, Zhu L, Cheng Y, Liu Z, Cai X, Shao J, et al.
BMC Cancer
. 2022 May;
22(1):506.
PMID: 35524205
Background: Preoperative chemoradiotherapy (CRT) with CROSS regimen has been the recommended treatment for locally advanced esophageal squamous cell carcinoma (ESCC). The addition of programmed cell death protein 1 (PD-1) inhibitor...
5.
Liu J, Yang Y, Liu Z, Fu X, Cai X, Li H, et al.
J Immunother Cancer
. 2022 Mar;
10(3).
PMID: 35338088
Background: Camrelizumab and chemotherapy demonstrated durable antitumor activity with a manageable safety profile as first-line treatment in patients with advanced esophageal squamous cell carcinoma (ESCC). This study aimed to evaluate...
6.
Cai X, Wu G, Zhang J, Yang L
Front Med (Lausanne)
. 2021 Dec;
8:719472.
PMID: 34938742
Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly around the world. Studies found that the incidence of acute kidney injury (AKI) in COVID-19 patients was more than double...
7.
Deng L, Liu W, Xu Q, Guo R, Zhang D, Ni J, et al.
Biomed Pharmacother
. 2021 Nov;
145:112383.
PMID: 34736077
Hypertension is one of the important causes of cardiovascular diseases, and the imbalance of vascular homeostasis caused by oxidative stress and endothelial inflammation occurs throughout hypertension pathogenesis. Therefore, inhibiting oxidative...
8.
9.
Lu W, Dong Y, Cui Q, Wang Y, Yang X, Cai X, et al.
Front Genet
. 2021 Jul;
12:628547.
PMID: 34305997
Objective: This study aimed to investigate the role and potential regulatory mechanism of citron kinase (CIT) in esophageal squamous cell carcinoma (ESCC). Methods: Citron kinase (CIT) expression in ESCC tissues...
10.
Zhou Y, Guo Y, Cui Q, Dong Y, Cai X, Zhang Z, et al.
Technol Cancer Res Treat
. 2020 Oct;
19:1533033820952351.
PMID: 33084538
Objective: Lung cancer is often associated with hypercoagulability. Thromboelastography provides integrated information on clot formation in whole blood. This study explored the possible relationship between thromboelastography and lung cancer. Methods:...